where to inject bpc 157 Peptide BPC-157 - Does It Work? Breaking Down the Evidence and the Hype The Hidden Risks of BPC‑157:

Vitamin B12 deficiencies can lead to megaloblastic anemia, or low red blood cell counts

Based on these data, the FDA approved tesamorelin (marketed as EGRIFTA) for the reduction of excess abdominal fat in HIVassociated lipodystrophy, not as a general weightloss drug for the wider population. Tesamorelin Risks and Considerations Like all hormonemodulating therapies, tesamorelin carries potential risks, including fluid retention, joint pain, injectionsite reactions, and effects on glucose metabolism in susceptible patients

When taken in conjunction with a diet and exercise plan, you may achieve up to a 5- to 10-pound weight loss

Nonarteritic ischemic optic neuropathy developing soon after use of sildenafil (viagra): a report of seven new cases